Fig 2.
(A) Disease-specific survival (DSS) for resected primary radiation-associated sarcomas (RASs) and (B) subtype-specific DSS for resected primary RASs (P = .004). LMS, leiomyosarcoma; AS, angiosarcoma; MFH, malignant fibrous histiocytoma; MPNST, malignant peripheral nerve sheath tumor; FS/MYXF, fibrosarcoma or myxofibrosarcoma.